Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 57   

Articles published

AZN 4,372.50 -119.50 (-2.66%)
price chart
AstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents Expire
Feb. 2 (Bloomberg) -- AstraZeneca Plc, the U.K.'s second-biggest drugmaker, fell the most in five months after saying profit this year will decline as the company prepares to face generic competition to top-selling medicines.
AstraZeneca Plans to Cut 7300 Jobs  Wall Street Journal
AstraZeneca closing Montreal R&D plant  Globe and Mail
Europe Job Losses Accelerate With AstraZeneca-to-PepsiCo Firing Employees
Feb. 13 (Bloomberg) -- Global companies from NEC Corp. to PepsiCo Inc. and AstraZeneca Plc are chopping jobs more than three times faster than in 2011 as they brace for recession in Europe and a slowdown in China.
Pfizer, AstraZeneca face revenue drop as patent protection expires
Pfizer Canada Inc. lost its bid to block the production of a generic eye drug by Apotex Inc. when the Supreme Court of Canada declined Thursday to hear the company's appeal.
AstraZeneca India job cuts likely to hurt drug research
New Delhi: Theextensive layoffs at London-listed drug maker AstraZeneca Plc's research outfits have hit India. On 13 February, the firm's Bangalore subsidiary laid off 19 employees—15 of them middle-level and senior scientists involved in the research ...
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents
Feb. 9 (Bloomberg) -- AstraZeneca Plc lost a U.S. appeals court bid to protect its best-selling drug, Crestor, from generic competition until as late as 2021.
Making the right exit: Lessons learned from AstraZeneca and IBM
The MSA also contained an obligation on AstraZeneca to produce an IT transfer plan for IBM detailing how the services would be transferred away from IBM.
Reckitt Benckiser shares boosted by outperformance
Shares in Reckitt Benckiser () moved higher as markets responded to its announcement that it had exceeded full-year targets for 2011 and posted a strategy to continue outperformance into 2012.
12 rules to beat the markets
Mike McCudden meets day-trading veteran David Rogerson and discovers how his 12 golden rules helped him to play with someone else's money and hit the jackpot.
Facebook unveils $5 billion IPO
After days of intense speculation Facebook has unveiled its plans for a $5 billion (�3.2 billion) initial public offering (IPO), filing papers with the Securities and Exchange Commission ( SEC ) late on Wednesday.
Am I in danger of losing half of my money?
Q: I have invested more than �90,000 in a stocks and shares ISA with Legal & General (L&G) by putting away a small amount each month since ISAs were launched and using up my annual allowance before the end of each financial year.